MedPage Today12m
How the FDA Opens the Door to Risky Chemicals in America's Food Supply
In 1958, Congress mandated that, before additives could be used in foods, manufacturers had to prove they were safe and get ...
Male enhancement capsules recalled for undeclared ingredients, FDA announces
One Source Nutrition, Inc. is voluntarily recalling all of its Vitality male enhancement capsules nationwide after an FDA ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
BioSpace13h
FDA Action Alert: GSK, Alnylam, Sanofi and More
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
Fierce Pharma3h
Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
FDA nominee pitches AI application review
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...
Hays Post1d
Trump nominee to head up FDA made no commitments on abortion pill access
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to ...
Fierce Pharma2h
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...
FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration.
Trump’s FDA nominee grilled on vaccine meeting, agency staffing
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...